Astellas’ fezolinetant fails to meet pre-defined endpoints for efficacy in Moonlight clinical…
Based on the 12-week data analysis in 302 participants, fezolinetant 30 mg once daily (QD) in women in China, Korea and Taiwan did…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Astellas Pharma
Healthcare industry reports 58 deals worth $12.4 bn in Dec’19
According to GlobalData, three big ticket deals together contributed 63 per cent to the total deal value in the month
Strides Pharma Science arm gets US FDA nod for drug to treat overactive bladder
The approved product is a generic version of Vesicare tablets of Astellas Pharma US